Drug intelligence / Profile preview

Felix

Development stage: Unknown

Overview

The term "Felix" is non-specific in the provided context, referring to several distinct entities rather than a single pharmaceutical drug. These include: a 40 Hz light neurostimulation therapy (FELIX) being investigated for Major Depressive Disorder and Treatment Resistant Depression; medical devices such as the "Felix system" and "Felix NeuroAI Wristband" for the relief of tremors in Essential Tremor and Parkinson's Disease; and "Phage Felix O1 (FO1)", a bacteriophage used in research and food safety settings for targeting Salmonella enterica. Other mentions of "Felix" refer to individuals, diagnostic tests (Weil-Felix test), experimental apparatus (FELIX laser), cell culture medium (FELIX medium), fracture classifications, and a skin color chart.

Brand names: Felix NeuroAI Wristband
Other names: Felix systemFELIX (40 Hz Light Neurostimulation)

Beyond the preview

Go deeper on Felix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Felix.

Explore the full profile